Glucagon analogues
US8541368B2 · kind B2 · utility
5Cited by
2References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2012 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Sep 21, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel glucagon peptides, to the use of said glucagon peptides in therapy, to methods of treatment comprising administration of said glucagon peptides to patients in need thereof, and to the use of said glucagon peptides in the manufacture of medicaments. The glucagon peptides of the present invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.